Gold Miners ETF Market Vectors (GDX) News 24.10

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gold Miners ETF Market Vectors (GDX) News 24.10 $GDX

Fool's Gold Report: Bullion Breaks $1,300, but Hecla, Pan American Move Higher
Dan Caplinger, The Motley Fool - Motley Fool - Thu Mar 27, 5:45PM CDT
Gold fell below the key $1,300 level Thursday, raising new fears about whether the yellow metal's rally to begin 2014 is now over. Yet, mining companies fared well today, with silver specialists Hecla Mining and Pan American Silver posting...

'Fast Money' Recap: Stressed by the Tests
at The Street - Thu Mar 27, 4:00AM CDT
The trading panel discussed the falling markets and the effect of the latest stress test results on banks.

Fool's Gold Report: Metals Drop Despite Ukraine Tensions; Can Gold Hold $1,300?
Dan Caplinger, The Motley Fool - Motley Fool - Wed Mar 26, 6:11PM CDT
One of the reasons cited for gold's advance earlier this year was the tension between Russia and Ukraine. When gold started falling more recently, one thing analysts pointed to was the lack of escalation following Russia's annexation of Crimea. Yet...

Fool's Gold Report: Central-Bank Buying Fails to Spur Big Gold Gains; Platinum-Group Metals Drop
Dan Caplinger, The Motley Fool - Motley Fool - Tue Mar 25, 4:44PM CDT
Gold is very much a market of supply and demand, and ordinarily, news of the biggest purchase by a national central bank in three years would be enough to make gold bulls very happy indeed. Yet on Tuesday, gold markets largely shrugged off the news,...

Fool's Gold Report: Gold Plunges, but Palladium Holds Strong
Dan Caplinger, The Motley Fool - Motley Fool - Mon Mar 24, 6:10PM CDT
On Monday, gold investors once again saw just how violent pullbacks can be in the precious-metals markets, as continued negative sentiment following last week's decline in gold prices led to an even sharper drop in prices. April gold futures fell $25...

SmarTrend Watching for Potential Rebound in Shares of Market Vectors - Gold Miners ETF After 4.68% Loss
Comtex SmarTrend(R) - Mon Mar 24, 3:46PM CDT
Market Vectors - Gold Miners ETF (AMEX:GDX) traded in a range yesterday that spanned from a low of $24.29 to a high of $25.22. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $25.16 on volume of 60.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Market Vectors - Gold Miners ETF Set to Possibly Rebound After Yesterday's Selloff of 4.68%
Comtex SmarTrend(R) - Mon Mar 24, 3:46PM CDT
Market Vectors - Gold Miners ETF (AMEX:GDX) traded in a range yesterday that spanned from a low of $24.29 to a high of $25.22. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $25.16 on volume of 60.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Fool's Gold Report: Silver, Platinum Keep Falling as Gold Recovers From Worst Losses
Dan Caplinger, The Motley Fool - Motley Fool - Thu Mar 20, 4:15PM CDT
On Thursday, investors continued to wrap their heads around the prospect of higher interest rates as soon as mid-2015, as disagreement about how serious Fed Chair Janet Yellen's comments about monetary policy were in indicating future Fed policy gave...

Fool's Gold Report: Yellen Sends Gold Plunging With Hawkish Comment; Miners Hit Hardest
Dan Caplinger, The Motley Fool - Motley Fool - Wed Mar 19, 6:06PM CDT
Wednesday proved to be an exciting day in the gold market, as initial declines on continuing stability in the Ukrainian situation and in the Chinese economy widened even further after Fed Chair Janet Yellen's comments at her post-FOMC meeting news...

How to Profit From Rising Gold Prices
Daniel Gibbs, The Motley Fool - Motley Fool - Wed Mar 19, 12:45PM CDT
On December 18, the Federal Reserve announced that it was slowing down quantitative easing and would buy less Treasury and agency securities. This was the start of the much awaited "taper" that the markets had been expecting for a good portion of...

Fool's Gold Report: Metals Fall As Investors Brace for the Fed
Dan Caplinger, The Motley Fool - Motley Fool - Tue Mar 18, 4:50PM CDT
On Tuesday, precious metals extended their pullback from yesterday, as gold traders continued to unwind short-term bullish positions based on the possibility for unrest in Ukraine following the Crimean referendum to reunite with Russia. As...

Market Vectors - Gold Miners ETF Falls 1.38% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Mar 18, 3:47PM CDT
Market Vectors - Gold Miners ETF (AMEX:GDX) traded in a range yesterday that spanned from a low of $26.26 to a high of $26.87. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $26.76 on volume of 35.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Watch for Market Vectors - Gold Miners ETF to Potentially Rebound After Falling 1.38% Yesterday
Comtex SmarTrend(R) - Tue Mar 18, 3:47PM CDT
Market Vectors - Gold Miners ETF (AMEX:GDX) traded in a range yesterday that spanned from a low of $26.26 to a high of $26.87. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $26.76 on volume of 35.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Gold Mining ETF Investing 101 - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 11:00AM CDT
After a terrible performance in 2013, gold mining ETFs are regaining some shine this year.

Investors Pause as Economic Sanctions Against Russia Loom
James Catlin, The Motley Fool - Motley Fool - Tue Mar 18, 10:20AM CDT
Since Russia inserted itself into the Ukrainian situation, the world has more questions than answers. Russian goals regarding this unilateral action are still unclear and the international community is growing more concerned. These concerns have...

Fool's Gold Report: Crimean Calm Sends Gold, Silver Slumping; Miners Fall
Dan Caplinger, The Motley Fool - Motley Fool - Mon Mar 17, 6:12PM CDT
After five days of rising gold prices last week, investors were expecting the worst from Crimea's referendum on reunification with Russia yesterday. Although they got the anticipated vote to leave Ukraine as well as economic sanctions on Russia as a...

Fool's Gold Report: Futures Hit New 6-Month Highs Before Crimean Vote
Dan Caplinger, The Motley Fool - Motley Fool - Fri Mar 14, 5:18PM CDT
For the fifth straight day this week, gold rose as the Dow Jones Industrials fell, with investors getting their last chance to take positions before a key referendum in the Crimean region of Ukraine this weekend. With many expecting the peninsula to...

Fool's Gold Report: Miners Jump on Ukraine Tensions; Bullion Prices Mixed
Dan Caplinger, The Motley Fool - Motley Fool - Thu Mar 13, 4:15PM CDT
Gold investors count on the yellow metal providing a safe haven during times of trouble, and with reports of U.S. fighters jets deploying to Poland amid Russian military exercises near the Ukrainian border, gains for gold would have been expected,...

Market Vectors - Gold Miners ETF Has Returned 16.7% Since SmarTrend Recommendation (GDX)
Comtex SmarTrend(R) - Thu Mar 13, 10:08AM CDT
SmarTrend identified an Uptrend for Market Vectors - Gold Miners ETF (AMEX:GDX) on January 17th, 2014 at $23.12. In approximately 2 months, Market Vectors - Gold Miners ETF has returned 16.72% as of today's recent price of $26.98.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BASIS Bellevue Expands with New K-4 Campus

Updated Category News Views 89

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

Continue Reading
Smirnoff Launches Marvel Event with $12.99 Offer

Updated Category News Views 68

Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...

Continue Reading
Ameritas Hires Actuarial Veteran as VP in Strategic Move

Updated Category News Views 115

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

Continue Reading
Amgen Q3 2026 Results: What Investors Should Know

Updated Category News Views 93

Amgen Prepares to Reveal Third Quarter 2026 Financials If there's one thing I've learned about investing, it's that the devil's in the details, and Amgen's (NASDAQ:AMGN) upcoming webcast for its third quarter 2026 financial results is exactly the kind of detail that sets market-watchers' hearts racing. Scheduled for November 3, just after the U.S. markets close, this is...

Continue Reading
Royce Global Trust: Insights on RGT's Performance

Updated Category News Views 80

Analyzing Royce Global Trust's Approach When you dig into the Royce Global Trust portfolio, what emerges is a tapestry woven through decades of grit and determination in the investing world. This closed-end fund, trading under the symbol NYSE: RGT, is no stranger to the ebbs and flows of global markets. With every tick of the clock, speculation dances around this fund's...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Bloomberg Law Awards Series Celebrates Legal Excellence

Updated Category News Views 54

New Awards Shine Light on Corporate Legal Teams Here's one for the books: Bloomberg Law is rolling out a shiny new awards program called Inside In-House: Legal Departments of the Year. Now, this isn't some vanity affair because it's aimed at celebrating the folks in legal teams who make companies tick behind the scenes. Openings for nominations run through November 20,...

Continue Reading
Oracle's Bold Vision: Targeting $225B Revenue by 2030

Updated Category News Views 132

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Continue Reading
BD's New Liverty™ TIPS Stent: A Game Changer?

Updated Category News Views 75

Could This Be the Breakthrough for Portal Hypertension? Now, here's something that might just turn a few heads in the medical world. BD has launched their Liverty™ TIPS Stent Graft in the U.S., a move set to shake up the landscape for treating portal hypertension. This isn't just another shiny new gadget—it's a promise of more personalized patient care in a field...

Continue Reading
Ascletis' ASC30 Achieves Significant HbA1c Reductions

Updated Category News Views 73

When you dive into the world of biopharma, you never quite know what's going to grab your attention next. Today, it's Ascletis Pharma's (HKEX: 1672) GLP-1 receptor agonist, ASC30, that's piqued my interest. It just wrapped up a U.S. Phase II study with a bang, showing off with some impressive results for type 2 diabetes treatment. This ain't no half-hearted...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading